Cancer Prevention and Control Program Summary

[Program Summary| Members Search ]

The primary scientific goal of the Cancer Prevention and Control (CPC) Program is to develop and implement basic, translational, clinical, and population-based epidemiologic research projects in primary, secondary and tertiary cancer prevention and control that integrate the scientific interests and expertise of a multi-disciplinary research team. The development and conduct of clinical and population-based cancer prevention and control research studies incorporate recruitment of high-risk subjects and minority populations; identification of risk factors; development of programs to decrease cancer incidence, to increase cancer survival, and to increase knowledge and practice of cancer screening behaviors among minority populations; and establishment of a statewide network of physicians in various fields, including surgeons, dermatologists, gastroenterologists, gynecologists, and urologists, to facilitate cancer prevention and control research. The following CPC Program Scientific Objectives have been established to support the primary scientific goal:

• To develop and conduct clinical and population-based epidemiologic cancer prevention and control research studies;

• To identify risk factors (e.g., environment, nutrition, physical activity), based on ongoing etiologic research, and assess the relationship of these risk factors to cancer development, translating research on intermediate cancer endpoints, molecular, genetic, biochemical and immunologic changes into strategies that can be appropriately used in an epidemiologic context;

• To develop and implement hypothesis-driven translational and basic science research studies related to cancer prevention and control;

• To investigate the molecular, genetic, phenotypic, biochemical, and immunologic alterations associated with carcinogenesis and to support the application of these results to molecular epidemiologic cancer research;

• To identify promising preventive interventions, perform preclinical toxicology studies, test the chemopreventive efficacy of these agents, and to investigate the effect of chemopreventive agents on the carcinogenesis process as represented by genetic, molecular, phenotypic, biochemical, and immunologic markers;

• To establish statewide networks of breast cancer surgeons, gastroenterologists, gynecologists, urologists and dermatologists to facilitate clinical cancer prevention and control research;

To identify and recruit high-risk subjects and underserved populations.

 

 

For more information, please contact: 

Peter Lance, M.D.

Co-Director, Cancer Prevention and Control Program
(520) 626 - 4768
Fax:  (520) 626-5348
e-mai l:  plance@azcc.arizona.edu

 

 

Elena Martinez

Co-Director, Cancer Prevention and Control Program
(520) 626 - 8130
Fax:  (520) 626 - 9275
e-mail:  emartinez@azcc.arizona.edu

 

 

Webmaster | Privacy Policy | Disclaimer
Arizona Cancer Center :: 1515 North Campbell Ave., Tucson, AZ 85724-5024
Copyright ABOR :: All rights reserved.